Side-by-side comparison of AI visibility scores, market position, and capabilities
CA AI corporate travel management via email/chat with McKinsey 30K+ bookings at 20% of US/Canada travel; YC W22 $4M with BCD Travel partnership and BTN Innovation Faceoff winner competing with Navan and SAP Concur.
SkyLink is a California-based AI-powered corporate travel management platform — backed by Y Combinator (W22) with $4 million raised from Abstract Ventures, BBQ Capital, Ethos Capital, Gemini Frontier Fund, YC, and 12 other investors — enabling enterprise employees to book and manage business travel through conversational interfaces (email and chat) rather than traditional travel management portals, achieving major deployments including McKinsey & Company (30,000+ bookings since March 2025, representing 20% of McKinsey's US/Canada corporate travel) and a strategic partnership with BCD Travel for large-scale North America deployment announced in July 2025. SkyLink won BTN Group's 2024 Innovation Faceoff Judges' Choice award, the corporate travel industry's most prestigious startup recognition.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.